Provides the same proven efficacy as PROIN (phenylpropanolamine hydrochloride) chewable tablets in extended-release tablets for once-a-day dosing. Our patented extended-release technology provides a controlled release mechanism that achieves steady absorption. For the control of canine urinary incontinence due to urethral sphincter hypotonus. Urethral sphincter hypotonus causes canine urinary incontinence as a result of weakened muscles of the urethral sphincter.
Signature is required upon delivery in the following states: Arkansas, Illinois, Iowa, Louisiana, Oregon, and West Virginia.